Clinical Trial Update: Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT [Phase 2]

View source ↗

Summary

A Phase 2 pilot randomized trial evaluating SGLT-2 inhibitors for recurrent ascites in cirrhosis, currently with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• SGLT-2 inhibitor

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Cirrhosis, Ascites Hepatic | Phase 2 | Status: UNKNOWN